The Oxford-AstraZeneca vaccine is less effective against the South African mutated variant, early data from a small study claimed to show last night in a development that will raise anxiety about global inoculation efforts. A small trial of just 2,026 people in South Africa found the jab had ‘limited efficacy’ in protecting against mild and moderate disease caused by the mutant strain, which has been found in 11 people in the UK who have not recently travelled from abroad. However nobody died or was hopitalised during the study by South Africa’s University of the Witwatersrand and Oxford University, which has not yet been published but has been seen by the Financial Times. The pharmaceutical giant said scientists have already begun adapting the vaccine to kill the new variant, with hopes a booster shot will be ready by autumn if required. Astrazeneca said it remains confident that its vaccine can prevent severe disease caused by the variant- and pointed out that the trial could not measure its effectiveness at preventing severe disease caused by the mutant strain because the median age of participants was 31. Nevertheless, the announcement will increase global government’s temptation to introduce stricter border controls to control the spread… Read full this story
- This Italian scientist has become a celebrity by fighting vaccine skeptics
- SARS fears in China as 27 patients are struck down with 'unidentified' type of pneumonia similar to the killer virus of the early 2000s
- AI can spot an irregular heartbeat from just a 10-second scan by looking for tiny signals that may be 'invisible to the human eye'
- Boris Johnson pledges 50,000 more NHS nurses, a five-year tax freeze and to 'get Brexit done' in 'sensible and moderate' Tory manifesto that promises 'a new chapter for Britain'... as Labour panic splurges ANOTHER £58BILLION of public spending
- Magic mushrooms could be prescribed for people with depression, new research suggests
- Therapy wars: the revenge of Freud
- Out of the laager
- Getting results: why NHS clinical trials are the envy of the world
- Ebola survivors suffer lingering health problems
- Woman who inherited fatal illness to sue doctors in groundbreaking case
Oxford coronavirus vaccine IS less effective against South African mutant strain found in UK, claim scientists: Small study of just 2,000 patients found some patients got mild or moderate symptoms - but NONE died or were hospitalised have 341 words, post on www.dailymail.co.uk at February 6, 2021. This is cached page on Europe Breaking News. If you want remove this page, please contact us.